In clinical and health research, mixed methods refers to a study approach that systematically combines and integrates quantitative and qualitative methods to answer research questions more comprehensively than any single approach alone. Quantitative methods such as randomized controlled trials or standardized questionnaires provide measurable, generalizable data on frequencies and causal relationships. Qualitative methods such as interviews, focus groups, or ethnographic observations capture subjective experiences, meanings, and contextual factors that cannot be captured by numbers alone. Combining both approaches makes it possible not only to measure clinical effects, but also to explain why they occur and under what conditions they increase or decrease.
Overview of design types
Mixed-methods designs differ in how and when qualitative and quantitative components are combined. In a convergent design, both strands are collected in parallel and the results are then integrated and compared. In an explanatory sequential design, the quantitative phase is followed by a qualitative in-depth phase that explains unexpected or notable findings. In an exploratory sequential design, the qualitative phase comes first and generates hypotheses or new measurement instruments for a subsequent quantitative study.
A key quality feature of mixed-methods studies is the integration of the two methodological strands. Simply placing two independently analyzed datasets side by side is not considered a true mixed-methods design in the methodological literature. Integration can occur at the level of the research question, data collection, analysis, or interpretation, and must be methodologically justified and clearly described in the study protocol. A missing or unclear integration strategy is the most common point of criticism among assessors and reviewers.
Application in clinical research
In clinical research, mixed-methods approaches are used primarily in health services research, implementation research, and in the development and validation of patient-reported outcomes. If a new treatment program does not achieve the expected effects in practice, a qualitative accompanying study can help to understand which organizational, cultural, or patient-related barriers hinder implementation. This information cannot be obtained in a purely quantitative effectiveness study.
Qualitative preliminary phases are also indispensable in the development of patient questionnaires and PRO instruments to ensure that items are understandable, relevant, and meaningful from the patient perspective. In its guidance on patient-reported outcomes, the FDA explicitly emphasizes the need for qualitative methods for concept elicitation and cognitive pretesting before an instrument is quantitatively validated.
Strengths and methodological limitations
The main strength of mixed-methods studies lies in complementarity: quantitative data provide breadth and statistical generalizability, while qualitative data provide depth and contextual understanding. Together, they enable a more complete answer to complex research questions. Triangulation—i.e., comparing results from both methods—can also strengthen the validity of conclusions when both sources converge on consistent findings.
Limitations include increased time and resource requirements and the need for interdisciplinary expertise within the research team. Quantitative and qualitative methods follow different epistemological traditions and require different analytical logics. In regulatory pivotal trials, mixed-methods approaches have so far played a minor role because confirmatory efficacy studies require standardized quantitative designs. However, their use is established and regulatorily recognized for supportive studies and PRO development.
Quality criteria and reporting
There are established guidelines for reporting mixed-methods studies, such as the Good Reporting of A Mixed Methods Study (GRAMMS) checklist or the recommendations of the Journal of Mixed Methods Research. These guidelines call, among other things, for a clear rationale for the mixed-methods approach, a detailed description of integration, and a critical reflection on methodological strengths and weaknesses. Dedicated synthesis methods also exist for systematic reviews of mixed-methods studies, such as mixed methods research synthesis, which systematically integrates both quantitative and qualitative findings.
In practice, the quality of mixed-methods studies is often weakened by unclear integration, a missing rationale for the design, and a lack of transparency in the analysis. Full-service CROs and research institutions conducting mixed-methods projects should involve experienced qualitative researchers early, define clear roles within the team, and explicitly document integration in the study protocol and results report. Only then can the full potential of the approach be realized. In addition, it is advisable to have a multidisciplinary team interpret the integrated results, bringing both clinical and methodological perspectives. Contradictory findings between the quantitative and qualitative components should not be regarded as errors, but used as a valuable source of insight, indicating complexity and context dependence of the phenomena under investigation and generating further research questions.
Frequently Asked Questions (FAQ)
Is a mixed-methods design accepted by regulators?
For confirmatory pivotal trials, quantitative, controlled designs are required. However, mixed-methods approaches are accepted and in some cases explicitly recommended for supportive studies, implementation research, and the development and validation of PRO instruments—for example, in the FDA PRO Guidance (2009) and in EMA guidelines on PRO development. Sponsors should plan the use of qualitative methods as early as the instrument development phase and document this transparently in the dossier.
What is the difference between mixed methods and triangulation?
Triangulation is one aspect of mixed methods in which multiple methods are used for mutual validation. Mixed methods is the overarching term and also includes designs in which methods are combined to complement or explain findings without aiming for mutual validation.
Does a mixed-methods design need to be registered in advance?
Yes, provided it is a study that is subject to mandatory registration. The registration requirement applies regardless of the mix of methods. It is advisable to register both parts of the protocol in advance to prevent selective reporting.